SAN DIEGO, May 27, 2020 — Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapies, NB-Lux™ speeds formulation development by providing real time pricing for cGMP grade media in lot sizes from two liters to 2000 liters. [Read more…]
Interview with the CEO of WideCells: Unlocking the Future of Cord Blood
CellPlan is a revolutionary stem cell insurance product launched by WideCells Group in Manchester, UK. WideCells Group aims to provide people with access to affordable stem cell treatments. In this interview, CEO Joao Andrade describes how the company will facilitate the therapeutic use of umbilical cord blood stem cells by providing worldwide access to stem cell specialists and hospitals.
In this article:
I Peace, Inc. Introduces Clinical-Grade iPS Cell Custom Manufacturing Service
PALO ALTO, Calif., May 15, 2020 — I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up focusing on Nobel Prize-wining technology “induced pluripotent stem cell (iPSC)” began manufacturing clinical-grade iPSCs. We are now officially taking orders for custom manufacturing of clinical-grade iPSCs from institutions around the world.
On March 11, 2020, the company received a license to manufacture clinical-grade cells from Japan’s Ministry of Health, Labour and Welfare for its cell manufacturing facility located in Kyoto, Japan. [Read more…]
FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19
First Patients treated with Organicell Flow through “Emergency Single Patient Compassionate Use” designation
MIAMI, May 19, 2020 — Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that on May 11, 2020, the U.S. Food and Drug Administration (FDA) authorized two Emergency Compassionate Use Investigational New Drug applications (eINDs), each for a single patient severely ill from COVID-19. These critical patients have received immediate administration of Organicell Flow. [Read more…]
Escalating Demand for Stem Cell Research Products During COVID-19
Released May 2020, this 251 page market report features market size data with detailed segmentation and 5-year projections (2020-2024).
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types.
There are now hundreds of companies developing stem cell research products — many of which are serving companies involved in the management of the largest pandemic in modern history. [Read more…]
- « Previous Page
- 1
- …
- 191
- 192
- 193
- 194
- 195
- …
- 336
- Next Page »